Want to join the conversation?
Biotechnology company $SHPG said the US District Court for the District of Delaware has ruled that Zydus Cadila's proposed generic version of Lialda does not infringe US Patent No. 6,773,720. Lialda is used to treat mild to moderate ulcerative colitis and for maintenance of ulcerative colitis remission.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)